Jamil Beg
Venture Capitalist & Bioentrepreneur
Jamil Beg
Venture Capitalist & Bioentrepreneur
Cambridge, Massachusetts
Overview
Work Experience
Partner
2024 - Current
SV Health Investors is a boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Founding Investor
2020
Clinical stage, small molecule company developing inhaled therapeutics for respiratory diseases
Board of Directors
2020
Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.
Raised $41,500,000.00 from Gimv, Atlas Venture and 5AM Ventures.
Founding Investor
2022
Stealth stage genetic renal disease company
Chief Executive Officer
2022 - 2023
Founder
2018
Clinical stage, precision neuroscience company developing small molecules to transform the lives of patients suffering from neurological diseases
Board of Directors
2018 - 2023
Chief Executive Officer
2018 - 2021
Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.
Raised $109,000,000.00 from Bioluminescence Ventures.
Partner
2017 - 2023
5AM Ventures is an early stage life science venture fund focused on company creation and investments in seed and Series A companies
5AM Ventures is a venture capital firm that aims to finance seed and early-stage life sciences companies.
Guest Lecturer
2019 - 2022
Board Observer
2018 - 2021
Clinical stage company developing transformative breakthrough therapies for patients with severe and rare disorders (IPO in July 2021)
Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.
Raised $238,600,000.00 from Johnson & Johnson Innovation – JJDC.
Board Member
2007 - 2021
BioBreak is a members-only community fostering connections among life sciences executives and investors.
Mentor
2017 - 2021
Board Observer
2017 - 2020
Clinical stage, gene therapy company developing treatments for inner ear disorders (IPO in June 2020; acquired by Eli Lilly in October 2022)
Akouos is a biotechnology company focusing on restoring and preserving hearing.
Raised $162,500,000.00 from Fidelity, PAG, New Enterprise Associates, Polaris Founders Capital, Novartis Venture Fund, Cormorant Asset Management, Pivotal bioVenture Partners, RA Capital Management, Surveyor Capital and Wu Capital.